Treatment of rosacea patients with broadband pulse light emission using smooth pulse and photon recirculation technologies

Cover Page


Cite item

Full Text

Abstract

Goal of the study. To assess the efficacy and safety of using broadband pulse light emission with smooth pulse and photon recirculation technologies in the treatment of patients suffering from erythematous and papulous subtypes of rosacea. Materials and methods. Sixty rosacea patients (21 male and 39 female) at the age of 25-65 including 38 patients with erythematous and 22 patients with papulous subtypes of rosacea underwent treatment using broadband pulse light emission (5-8 treatment sessions). Results. After one month of treatment with broadband pulse light emission using smooth pulse and photon recirculation technologies: 68.4% of patients with the erythematous subtype had clinical recovery, and 31.6% - improvement; 27.2% of patients with the papulous subtype - clinical recovery, 54.5% - improvement, and 18.3% had no effect. After 5 months of treatment most of the patients still had a positive effect of the therapy, yet 21.1% of patients with the erythematous subtype and 11% of patients with the papulous subtype had single telangiectasias, increased erythema and single papules. After 10 months of treatment 44.7% of patients with the erythematous subtype of rosacea had an increase in the number of enlarged vessels, and 18.3% of patients with the papulous subtype had signs of a recurrence of the disease. Conclusion. The use of broadband pulse light emission with smooth pulse and photon recirculation technologies has a multiple, painless and significant effect on large lesions in the treatment of patients suffering from erythematous and papulous subtypes of rosacea.

About the authors

A. A. Kubanova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: info@cnikvi.ru
Russian Federation

Y. B. Makhakova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: info@cnikvi.ru
Russian Federation

References

  1. Zouboulis C., Katsambas A., Kligman A. Pathogenesis and Treatment of Acne and Rosacea. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014.
  2. Sirmajs N.S., Ustinov M.V. Ocenka jeffektivnosti terapii rozacea izotretinoinom. Klin dermatol venerol 2011; (6): 67-71.
  3. Chauhan N., Ellis D.A. Rosacea: pathophysiology and management principles. Facial Plast Surg Clin North Am 2013; 21 (1): 127-136.
  4. Steinhoff M. et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15 (1): 2-11.
  5. Obgol'c I.A., Nemchaninova O.B. Novye pod-hody k terapii rozacea. Sovrem probl dermatovenerol, immunol i vrach kosmetol 2010; (4): 15-19.
  6. Kubanova A.A., Makhakova Yu.B., Krupatkin A.I. Complex non-invasive methods of investigation of the pathophysiological processes in the skin of patients with rosacea. Vestn dermatol venerol 2015; (3): 75-86.
  7. Schoenewolf N.L., Barysch M.J., Dummer R. Basics in Dermatological Laser Applications. Curr. Probl. Dermatol. ed. Bogdan-Allemann I., Goldberg D.J. Basel: KARGER 2011; 42: 166-172.
  8. Babilas P. et al. Intense pulsed light (IPL): a review. Lasers Surg Med 2010; 42 (2): 93-104.
  9. Papageorgiou P. et al. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol 2008; 159 (3): 628-632.
  10. Koval'chuk L.A., Goncharuk V.Yu. Opyt lecheniya bol'nykh rozatsea. UO «Grodnenskiy gosudarstvennyy meditsinskiy universitet», 2012; 64-67.
  11. Kawana S., Ochiai H., Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg 2007; 33 (4): 449-454.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Kubanova A.A., Makhakova Y.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies